In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.

Systems controlled by next-generation computing algorithms could give rise to better and more efficient machine learning products, a new study suggests. Systems controlled by next-generation computing ...